Teknoloji Yatirim

Teknoloji Yatirim is a pioneering early-stage Turkish investor headquartered in Ankara, deploying $250k-$1M cheques at Seed and Series A into deep-tech and health startups, including biotech, medical devices, and AI/ML in healthcare. The firm has built a recognisable position in Turkish deep-tech with portfolio companies including Cellsway, signalling genuine appetite for technically ambitious life sciences and medtech founders. For founders, Teknoloji Yatirim is best positioned as an Ankara-anchored deep-tech lead with patient capital and meaningful regulatory and government access in the Turkish ecosystem. The right founder profile is a technically credible Turkish operator with strong research or engineering pedigree building a defensible biotech, medical device, or AI clinical product, with early validation and a clear regulatory pathway through TITCK and CE. Founders running consumer wellness, asset-heavy clinic models, or pure commercial plays without technical depth are a poor fit. Entry path is via the Ankara deep-tech ecosystem (METU, Hacettepe, Bilkent), a Teknoloji Yatirim portfolio CEO, or warm introductions from Istanbul-based deep-tech funds (ACT, Bogazici Ventures). In the pitch, lead with technical defensibility, IP strategy, regulatory positioning, clinical validation roadmap, and a credible international expansion plan that contemplates US or EU follow-on capital at Series A and beyond. Caveats: Turkey’s macro and currency volatility constrain valuation expectations and follow-on round sizing, so founders should plan international leads early. Deep-tech investing requires patient capital and longer cycle times to commercial maturity. Public deal footprint is modest, so request a recent deal sheet to confirm pacing, current vintage, and reserves policy during initial diligence, and clarify follow-on commitment explicitly.